Bristol-Myers Squibb HIV Drug Fast-Tracked

27.07.2015 - The US Food and Drug Administration has designated the Bristol-Mayers Squibb experimental HIV drug BMS-663068 as a breakthrough treatment, which could accelerate its approval. The...